Leukocyte specificity and binding of human neutrophil attractant/activation protein-1

E. J. Leonard, A. Skeel, Teizo Yoshimura, K. Noer, S. Kutvirt, D. Van Epps

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Neutrophil attractant/activation protein-1 (NAP-1) was previously shown to attract human neutrophils, but not monocytes. The purpose of this study was to determine if NAP-1 interacted with other types of blood leukocytes. In addition to its chemotactic activity for neutrophils, NAP-1 induced chemotactic responses by T lymphocytes and basophils. Chemotactic potency (10-8 M for an optimal response) was the same for all three cell types. However, NAP-1 caused a chemotactic response in excess of random migration of 7% or 16% of basophils (depending on the medium used) and only 9% of T lymphocytes, in contrast to 30% of neutrophils. This agonist was not chemotactic for partially purified normal human eosinophils. The symmetrical histogram obtained by flow cytometry of neutrophils equilibrated at 0°C with fluoresceinated NAP-1 indicates that all neutrophils bound the ligand. A dose-response curve plateau, and inhibition of binding of NAP-1-FITC by unlabeled ligand are evidence for saturable binding to receptors, estimated to be 7000 per cell. Our results suggest that, for induction of an acute inflammatory response, the quantitatively significant action of NAP-1 is on neutrophils.

Original languageEnglish
Pages (from-to)1323-1330
Number of pages8
JournalJournal of Immunology
Volume144
Issue number4
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

Neutrophil Activation
Leukocytes
Neutrophils
Proteins
Basophils
Ligands
T-Lymphocytes
Fluorescein-5-isothiocyanate
Eosinophils
Monocytes
Flow Cytometry

ASJC Scopus subject areas

  • Immunology

Cite this

Leonard, E. J., Skeel, A., Yoshimura, T., Noer, K., Kutvirt, S., & Van Epps, D. (1990). Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. Journal of Immunology, 144(4), 1323-1330.

Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. / Leonard, E. J.; Skeel, A.; Yoshimura, Teizo; Noer, K.; Kutvirt, S.; Van Epps, D.

In: Journal of Immunology, Vol. 144, No. 4, 1990, p. 1323-1330.

Research output: Contribution to journalArticle

Leonard, EJ, Skeel, A, Yoshimura, T, Noer, K, Kutvirt, S & Van Epps, D 1990, 'Leukocyte specificity and binding of human neutrophil attractant/activation protein-1', Journal of Immunology, vol. 144, no. 4, pp. 1323-1330.
Leonard, E. J. ; Skeel, A. ; Yoshimura, Teizo ; Noer, K. ; Kutvirt, S. ; Van Epps, D. / Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. In: Journal of Immunology. 1990 ; Vol. 144, No. 4. pp. 1323-1330.
@article{d4902e7e690d43e0b1901694185fc1a4,
title = "Leukocyte specificity and binding of human neutrophil attractant/activation protein-1",
abstract = "Neutrophil attractant/activation protein-1 (NAP-1) was previously shown to attract human neutrophils, but not monocytes. The purpose of this study was to determine if NAP-1 interacted with other types of blood leukocytes. In addition to its chemotactic activity for neutrophils, NAP-1 induced chemotactic responses by T lymphocytes and basophils. Chemotactic potency (10-8 M for an optimal response) was the same for all three cell types. However, NAP-1 caused a chemotactic response in excess of random migration of 7{\%} or 16{\%} of basophils (depending on the medium used) and only 9{\%} of T lymphocytes, in contrast to 30{\%} of neutrophils. This agonist was not chemotactic for partially purified normal human eosinophils. The symmetrical histogram obtained by flow cytometry of neutrophils equilibrated at 0°C with fluoresceinated NAP-1 indicates that all neutrophils bound the ligand. A dose-response curve plateau, and inhibition of binding of NAP-1-FITC by unlabeled ligand are evidence for saturable binding to receptors, estimated to be 7000 per cell. Our results suggest that, for induction of an acute inflammatory response, the quantitatively significant action of NAP-1 is on neutrophils.",
author = "Leonard, {E. J.} and A. Skeel and Teizo Yoshimura and K. Noer and S. Kutvirt and {Van Epps}, D.",
year = "1990",
language = "English",
volume = "144",
pages = "1323--1330",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Leukocyte specificity and binding of human neutrophil attractant/activation protein-1

AU - Leonard, E. J.

AU - Skeel, A.

AU - Yoshimura, Teizo

AU - Noer, K.

AU - Kutvirt, S.

AU - Van Epps, D.

PY - 1990

Y1 - 1990

N2 - Neutrophil attractant/activation protein-1 (NAP-1) was previously shown to attract human neutrophils, but not monocytes. The purpose of this study was to determine if NAP-1 interacted with other types of blood leukocytes. In addition to its chemotactic activity for neutrophils, NAP-1 induced chemotactic responses by T lymphocytes and basophils. Chemotactic potency (10-8 M for an optimal response) was the same for all three cell types. However, NAP-1 caused a chemotactic response in excess of random migration of 7% or 16% of basophils (depending on the medium used) and only 9% of T lymphocytes, in contrast to 30% of neutrophils. This agonist was not chemotactic for partially purified normal human eosinophils. The symmetrical histogram obtained by flow cytometry of neutrophils equilibrated at 0°C with fluoresceinated NAP-1 indicates that all neutrophils bound the ligand. A dose-response curve plateau, and inhibition of binding of NAP-1-FITC by unlabeled ligand are evidence for saturable binding to receptors, estimated to be 7000 per cell. Our results suggest that, for induction of an acute inflammatory response, the quantitatively significant action of NAP-1 is on neutrophils.

AB - Neutrophil attractant/activation protein-1 (NAP-1) was previously shown to attract human neutrophils, but not monocytes. The purpose of this study was to determine if NAP-1 interacted with other types of blood leukocytes. In addition to its chemotactic activity for neutrophils, NAP-1 induced chemotactic responses by T lymphocytes and basophils. Chemotactic potency (10-8 M for an optimal response) was the same for all three cell types. However, NAP-1 caused a chemotactic response in excess of random migration of 7% or 16% of basophils (depending on the medium used) and only 9% of T lymphocytes, in contrast to 30% of neutrophils. This agonist was not chemotactic for partially purified normal human eosinophils. The symmetrical histogram obtained by flow cytometry of neutrophils equilibrated at 0°C with fluoresceinated NAP-1 indicates that all neutrophils bound the ligand. A dose-response curve plateau, and inhibition of binding of NAP-1-FITC by unlabeled ligand are evidence for saturable binding to receptors, estimated to be 7000 per cell. Our results suggest that, for induction of an acute inflammatory response, the quantitatively significant action of NAP-1 is on neutrophils.

UR - http://www.scopus.com/inward/record.url?scp=0025022361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025022361&partnerID=8YFLogxK

M3 - Article

C2 - 2406341

AN - SCOPUS:0025022361

VL - 144

SP - 1323

EP - 1330

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -